跳至主要内容
临床试验/NCT06106139
NCT06106139Unknown1 期

The Effectiveness of Ketogenic Diet in Preventing or Improving Thrombocytopenia in Cancer Patients Undergoing Chemotherapy: a Randomized Controlled Single Blind Study

Baoling Guo0 个研究点目标入组 80 人开始时间: 2024年5月12日最近更新:
适应症
干预措施

试验速览

阶段
1 期
发起方
入组人数
80
主要终点
thrombocytopenia

研究概览

简要总结

The main purpose of this study is to evaluate whether dietary intervention through ketogenic diet can prevent or improve chemotherapy related thrombocytopenia in cancer patients.

详细描述

In the study, 80 patients with malignant solid tumors undergoing chemotherapy were randomly assigned to the normal diet group, the strict ketogenic diet group, the circulating ketogenic diet group, and the autonomous ketogenic group. During the chemotherapy period, the corresponding dietary intervention was carried out, and the clinical data of patients before and after treatment were collected, including blood routine, blood ketone concentration, weight, blood sugar, blood lipids, adverse events, and changes in platelets before and after chemotherapy, Statistical analysis of data such as the change degree of platelets and the incidence of adverse events in each diet group before and after treatment was carried out to evaluate the impact of ketogenic diet on clinical indicators and adverse reactions of chemotherapy in cancer patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18 and 90, regardless of gender
  • ECOG score ≤ 2 points
  • Received or expected to receive radiotherapy and chemotherapy during tumor activity
  • Body mass index 19-29
  • Conscious and autonomous eaters

排除标准

  • Patients with basic diseases of diabetes
  • Complications such as severe liver and kidney dysfunction or digestive tract obstruction, inability to eat
  • Those who have a preference for food and have strict requirements for dietary taste
  • Disagree to sign informed consent
  • Those whose physical conditions are determined by the doctor to be impermissible

研究组 & 干预措施

Normal diet group

No Intervention

This group of patients follows the "Dietary Guidelines for Chinese Residents (2022)" to ensure balanced nutrition, with daily calorie intake ranging from 1600 to 2400 kcal.

Strict ketogenic diet group

Experimental

the patients ate ketogenic biscuits or ketogenic foods provided by the researchers every day. During the study, the patients were not allowed to drink any drinks or eat other foods except drinking water, so as to ensure that the daily intake of calories was roughly the same as that of the normal diet group.

干预措施: Strict ketogenic diet group (Dietary Supplement)

Cyclic ketogenic diet group

Experimental

the patients took 7 days as a cycle, and 7 days of strict ketogenic diet+7 days of normal diet as a cycle. During the strict ketogenic diet, the patient should eat the ketogenic biscuit or ketogenic food provided by the researcher every day, and should not drink any beverage or eat other food except drinking water; During the normal diet period, patients followed the "Dietary Guidelines for Chinese Residents (2022)" to ensure nutritional balance. During the study period, patients were guaranteed to eat approximately the same amount of calories per day as the normal diet group.

干预措施: Cyclic ketogenic diet group (Dietary Supplement)

Autonomous ketogenesis group

Experimental

Patients choose ingredients for cooking and consumption under the guidance of researchers, ensuring that the nutritional composition is about 90% fat, 10% protein, and can contain a small amount of carbohydrates (10%). The daily calorie intake is around 1600~2400 kcal.

干预措施: Autonomous ketogenesis group (Dietary Supplement)

结局指标

主要结局

thrombocytopenia

时间窗: During radiotherapy and chemotherapy, approximately 3 months

次要结局

未报告次要终点

研究者

发起方
Baoling Guo
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Baoling Guo

associate chief physician

Fujian Medical University

相似试验